{"organizations": [], "uuid": "7b2c29b17de80a80c86743a21ae6cf9d51b40fd3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180507.html", "section_title": "Archive News &amp; Video for Monday, 07 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhejiang-hisun-pharmaceutical-rece/brief-zhejiang-hisun-pharmaceutical-receives-gmp-certificates-idUSL3N1SE3KL", "country": "US", "domain_rank": 408, "title": "Zhejiang Hisun Pharmaceutical receives GMP certificates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.628, "site_type": "news", "published": "2018-05-07T18:23:00.000+03:00", "replies_count": 0, "uuid": "7b2c29b17de80a80c86743a21ae6cf9d51b40fd3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhejiang-hisun-pharmaceutical-rece/brief-zhejiang-hisun-pharmaceutical-receives-gmp-certificates-idUSL3N1SE3KL", "ord_in_thread": 0, "title": "Zhejiang Hisun Pharmaceutical receives GMP certificates", "locations": [], "entities": {"persons": [], "locations": [{"name": "zhejiang hisun pharmaceutical", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "zhejiang hisun pharmaceutical co ltd", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "zhejiang food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 7 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd\n* Says it received goods manufacture practice (GMP) certificates from Zhejiang Food and Drug Administration\n* Certificate issued to crude drugs and antineoplastic drugs manufactured by the company and the valid period is until 2023\nSource text in Chinese: goo.gl/Zy4x5Q\n (Beijing Headline News)\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.facebook.com/Reuters", "https://goo.gl/Zy4x5Q", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://instagram.com/reuters/"], "published": "2018-05-07T18:23:00.000+03:00", "crawled": "2018-05-08T16:50:21.008+03:00", "highlightTitle": ""}